Search

Search Constraints

You searched for: Author/Creator Taneda, Shinji

Search Results

2. Effects of pemafibrate on lipid metabolism in patients with type 2 diabetes and hypertriglyceridemia: A multi-center prospective observational study, the PARM-T2D study. (October 2022)

3. Effects of switching from a dipeptidyl peptidase-4 inhibitor to oral semaglutide on glucose metabolism in patients with type 2 diabetes: protocol for a multicentre, prospective, randomised, open-label, parallel-group comparison study (the SWITCH-SEMA 2 study). Issue 5 (18th May 2022)

4. Favorable effect of sodium–glucose cotransporter 2 inhibitor, dapagliflozin, on non‐alcoholic fatty liver disease compared with pioglitazone. Issue 7 (2nd December 2020)

5. Impact of endogenous insulin secretion on the improvement of glucose variability in Japanese patients with type 2 diabetes treated with canagliflozin plus teneligliptin. Issue 8 (21st January 2021)

6. Improved time in range and postprandial hyperglycemia with canagliflozin in combination with teneligliptin: Secondary analyses of the CALMER study. Issue 8 (5th February 2021)

7. Insulin degludec/insulin aspart versus biphasic insulin aspart 30 in Asian patients with type 2 diabetes inadequately controlled on basal or pre-/self-mixed insulin: A 26-week, randomised, treat-to-target trial. Issue 1 (January 2015)

9. Localized Subcutaneous Insulin-Derived Amyloidosis Excised after Evaluation Using Ultrasonography in a Patient with Type 2 Diabetes Mellitus. (18th December 2017)

10. The agreement between measured HbA1c and optimized target HbA1c based on the Dementia Assessment Sheet for Community‐based Integrated Care System 8‐items (DASC‐8): A cross‐sectional study of elderly patients with diabetes. Issue 8 (30th June 2022)